Measuring physical activity in people with neuromuscular disorders
Measuring Physical Activity Levels and Intensity Using an ActivPal™ Accelerometer in Adult and Pediatric Populations With Neuromuscular Diseases
This study is trying to see how much people with neuromuscular disorders move around by having them wear a device on their leg for a week every six months over three years.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 1 Year and up |
| Sex | All |
| Sponsor | Columbia University Academic / other |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06084026 on ClinicalTrials.gov |
What this trial studies
This observational study aims to measure the level of physical activity in participants diagnosed with neuromuscular disorders. Participants will wear a small device on their leg for one week every six months over a three-year period, alongside undergoing physical exams, a six-minute walk test, vital sign assessments, and questionnaires. The study seeks to gather valuable data on physical activity patterns, which can help clinicians better understand disease progression and patient health. By utilizing consumer wearables, the study aims to bridge the gap in physical activity monitoring for individuals with rare diseases.
Who should consider this trial
Good fit: Ideal candidates include individuals with clinically or genetically confirmed neuromuscular disorders and control subjects without such conditions, aged one year and older.
Not a fit: Patients with conditions that may compromise their safety or compliance, as determined by the investigator, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide clinicians with a more accurate profile of disease progression in patients with neuromuscular disorders.
How similar studies have performed: Other studies utilizing similar wearable technology for monitoring physical activity in various populations have shown promising results, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with a clinically or genetically confirmed neuromuscular disorder * Control subjects who do not have a neuromuscular disease. * Participants at least 1 years of age. Exclusion Criteria: * Participant has a condition, which in the opinion of the Investigator may compromise safety * Participant has a condition, which in the opinion of the Investigator may compromise or compliance
Where this trial is running
New York, New York
- Columbia University Irving Medical Center — New York, New York, United States (Recruiting)
Study contacts
- Principal investigator: Michio Hirano, MD — Columbia University
- Study coordinator: Michio Hirano, MD
- Email: mh29@cumc.columbia.edu
- Phone: 1-212-305-1319
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.